Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin

Yuuki Komuro, Yasuhiro Udagawa, Nobuyuki Susumu, Daisuke Aoki, Tetsuro Kubota, Shiro Nozawa

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin'. Together they form a unique fingerprint.

Medicine & Life Sciences